The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans
- 1 June 1991
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 20 (6), 477-490
- https://doi.org/10.2165/00003088-199120060-00004
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitusKlinische Wochenschrift, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Clinical Pharmacokinetics and Endocrine Disorders Therapeutic ImplicationsClinical Pharmacokinetics, 1987
- Epidemiologic Approach to the Etiology of Type I Diabetes Mellitus and Its ComplicationsNew England Journal of Medicine, 1987
- Bioavailability and Disposition of Metoclopramide after Single‐ and Multiple‐Dose Administration in Diabetic Patients with GastroparesisThe Journal of Clinical Pharmacology, 1987
- Prescription drug use among diabetics—A population studyJournal of Chronic Diseases, 1987
- Effect of Blood Glucose Control on Increased Glomerular Filtration Rate and Kidney Size in Insulin-Dependent DiabetesNew England Journal of Medicine, 1985
- A pharmaceutical profile of diabetic patientsJournal of Chronic Diseases, 1983
- Bioavailability, Pharmacokinetics and Effects of Glipizide in Type 2 DiabeticsClinical Pharmacokinetics, 1982
- A study on the physiological disposition of acetophenetidin by the diabetic manComparative and General Pharmacology, 1974